The changing prevalence and incidence of dementia over time — current evidence
Yu‐Tzu Wu(Singer (United States)), Carol Brayne(University of Cambridge), Laura Fratiglioni(Stockholm University), Catherine Helmer(Inserm), Karine Pérès(Bordeaux Population Health), M. Arfan Ikram(Erasmus MC), Hugh C. Hendrie(Indiana University School of Medicine), Ingmar Skoog(Sahlgrenska University Hospital), Hiroyuki Honda(Kyushu University), Britt-Marie Sjölund(Stockholm University), Alexa Beiser(Boston University), Chengxuan Qiu(Karolinska Institutet), Kenneth M. Langa(University of Michigan–Ann Arbor), Monique M.B. Breteler(German Center for Neurodegenerative Diseases), Fiona E. Matthews(Newcastle University), Tomoyuki Ohara(Kyushu University), António Lobo(Universidad de Zaragoza), Sudha Seshadri(American Heart Association)
Cited by 773
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Global prevalence of dementia: a Delphi consensus study
|The Lancet|2005|5.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k